Racial variation in clinical and immunological manifestations of systemic sclerosis

被引:0
|
作者
Nietert, PJ
Mitchell, HC
Bolster, MB
Shaftman, SR
Tilley, BC
Silver, RM
机构
[1] Med Univ S Carolina, Dept Biostat Bioinformat & Epidemiol, Charleston, SC USA
[2] Med Univ S Carolina, Dept Med, Charleston, SC USA
[3] Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC USA
关键词
scleroderma; continental population groups; racial disparities; autoantibodies; demographics; clinical manifestations;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To clarify which racial differences in disease manifestations can be attributed to differences in other factors such as gender, education, disease classification, and disease duration. Methods. The study included white and black patients with systemic sclerosis (SSc) treated at a university hospital rheumatology clinic between November 1997 and April 2003. Demographic, clinical, and immunological measurements were obtained on each subject. Using multivariable statistical techniques we assessed differences in disease manifestations between white and black patients after adjusting for gender and classification and duration of disease. Results. Two hundred sixty-three patients (199 whites, 64 blacks) were enrolled in the study. Blacks experienced an earlier age at disease onset than whites and were significantly more likely to have diffuse disease, digital ulcers, digital pitting, impaired lung function, and anti-RNP, and anti-Ro antibodies. Whites were significantly more likely to have anti-centromere antibodies. Conclusion. After adjusting for gender, disease classification, and disease duration, whites and blacks with SSc differ in some clinical and immunological manifestations of disease. Whether these differences can be attributed to genetic or environmental factors remains unknown.
引用
收藏
页码:263 / 268
页数:6
相关论文
共 50 条
  • [31] Gastrointestinal manifestations in systemic sclerosis
    Szamosi, S
    Szekanecz, Z
    Szegedi, G
    Szúcs, G
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 279 - 279
  • [32] Gastrointestinal manifestations of systemic sclerosis
    Shreiner, Andrew B.
    Murray, Charles
    Denton, Christopher
    Khanna, Dinesh
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2016, 1 (03) : 247 - 256
  • [33] Gastrointestinal manifestations of systemic sclerosis
    Domsic, Robyn
    Fasanella, Kenneth
    Bielefeldt, Klaus
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (05) : 1163 - 1174
  • [34] NASAL MANIFESTATIONS OF SYSTEMIC IMMUNOLOGICAL DISORDERS
    FALKOFF, RJ
    EAR NOSE & THROAT JOURNAL, 1986, 65 (05): : 231 - 234
  • [35] Immunological basis of systemic sclerosis
    Zuber, J-P.
    Spertini, F.
    RHEUMATOLOGY, 2006, 45 : 23 - 25
  • [36] Racial Disparities in Systemic Sclerosis
    Moore, Duncan F.
    Steen, Virginia D.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2020, 46 (04) : 705 - 712
  • [37] Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis
    Kumar, S.
    Singh, J.
    Rattan, S.
    DiMarino, A. J.
    Cohen, S.
    Jimenez, S. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (07) : 883 - 898
  • [38] CLINICAL AND LABORATORY MANIFESTATIONS OF RNP-POSITIVE PATIENTS WITH SYSTEMIC SCLEROSIS
    Ananyeva, L. P.
    Shayakhmetova, R. U.
    Koneva, O. A.
    Starovoitova, M. N.
    Desinova, Q. V.
    Ovsyannikova, O. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1287 - 1287
  • [39] Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus
    Vilá, LM
    Mayor, AM
    Valentín, AH
    García-Soberal, M
    Vilá, S
    LUPUS, 1999, 8 (04) : 279 - 286
  • [40] Changes in Plasma Phospholipid Metabolism Are Associated with Clinical Manifestations of Systemic Sclerosis
    Geroldinger-Simic, Marija
    Boegl, Thomas
    Himmelsbach, Markus
    Sepp, Norbert
    Buchberger, Wolfgang
    DIAGNOSTICS, 2021, 11 (11)